Class,Class2,Class3,Generic_nameInsulin and analogue,Insulin analogue,fast-acting,Insulin lisproInsulin and analogue,Insulin analogue,fast-acting,Insulin aspartInsulin and analogue,Insulin analogue,fast-acting,Insulin glulisineInsulin and analogue,Insulin analogue,intermediate-acting,Insulin lisproInsulin and analogue,Insulin analogue,long-acting,Insulin glargineInsulin and analogue,Insulin analogue,long-acting,Insulin detemirInsulin and analogue,Insulin analogue,long-acting,Insulin degludecInsulin and analogue,Human insulin,fast-acting,Insulin humanInsulin sensitizer,Biguanide,Biguanide,MetforminInsulin sensitizer,Biguanide,Biguanide,BuforminInsulin sensitizer,Thiazolidine,Thiazolidine,RosiglitazoneInsulin sensitizer,Thiazolidine,Thiazolidine,PioglitazoneInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),SitagliptinInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),VildagliptinInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),SaxagliptinInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),AlogliptinInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),LinagliptinInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),TeneligliptinInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),AnagliptinInsulin secretion promoter,DPP-4 inhibitor(DG01601),DPP-4 inhibitor(DG01601),TrelagliptinInsulin secretion promoter,Sulfonylurea (SU),first generation,ChlorpropamideInsulin secretion promoter,Sulfonylurea (SU),first generation,TolbutamideInsulin secretion promoter,Sulfonylurea (SU),first generation,AcetohexamideInsulin secretion promoter,Sulfonylurea (SU),first generation,GlyclopyramideInsulin secretion promoter,Sulfonylurea (SU),second generation,GlyburideInsulin secretion promoter,Sulfonylurea (SU),second generation,GliclazideInsulin secretion promoter,Sulfonylurea (SU),third generation,GlimepirideInsulin secretion promoter,Sulfonylurea (SU),third generation,TolazamideInsulin secretion promoter,Sulfonylurea (SU),third generation,GlipizideInsulin secretion promoter,GLP-1 receptor agonist,GLP-1 receptor agonist,ExenatideInsulin secretion promoter,GLP-1 receptor agonist,GLP-1 receptor agonist,LiraglutideInsulin secretion promoter,GLP-1 receptor agonist,GLP-1 receptor agonist,LixisenatideInsulin secretion promoter,GLP-1 receptor agonist,GLP-1 receptor agonist,AlbiglutideInsulin secretion promoter,GLP-1 receptor agonist,GLP-1 receptor agonist,DulaglutidePostprandial hyperglycemia improving agent,"Insulin secretion promoter, fast-acting",Glinide(DG01735),RepaglinidePostprandial hyperglycemia improving agent,"Insulin secretion promoter, fast-acting",Glinide(DG01735),NateglinidePostprandial hyperglycemia improving agent,"Insulin secretion promoter, fast-acting",Glinide(DG01735),MitiglinidePostprandial hyperglycemia improving agent,Polysaccharide-degrading enzyme inhibitor,Alpha-glucosidase inhibitor(DG01663)),AcarbosePostprandial hyperglycemia improving agent,Polysaccharide-degrading enzyme inhibitor,Alpha-glucosidase inhibitor(DG01663)),MiglitolPostprandial hyperglycemia improving agent,Polysaccharide-degrading enzyme inhibitor,Alpha-glucosidase inhibitor(DG01663)),VogliboseUrine sugar eliminant,Urine sugar eliminant,SGLT2 inhibitor(DG01794),DapagliflozinUrine sugar eliminant,Urine sugar eliminant,SGLT2 inhibitor(DG01794),CanagliflozinUrine sugar eliminant,Urine sugar eliminant,SGLT2 inhibitor(DG01794),EmpagliflozinUrine sugar eliminant,Urine sugar eliminant,SGLT2 inhibitor(DG01794),TofogliflozinUrine sugar eliminant,Urine sugar eliminant,SGLT2 inhibitor(DG01794),LuseogliflozinUrine sugar eliminant,Urine sugar eliminant,SGLT2 inhibitor(DG01794),Ipragliflozin